Geographic Atrophy Treatment Market Expected to See Strong Growth

Geographic Atrophy Market

(Albany, USA) The Geographic Atrophy Market analysis report from DelveInsight presents a comprehensive analysis of the epidemiological analysis of Geographic Atrophy focusing on the incidence and the group of diagnosed patients segmented on the basis of several factors, as well as the analysis of the geographic atrophy market in the 7MM (the United States, EU5 (United Kingdom, France, Germany, Italy and Spain) and Japan).

The report covers Geographic Atrophy market trends covering major pharmaceutical companies in the market, upcoming marketed therapies as well as Geographic Atrophy, unmet needs, dominant restraints and factors driving the growth of the size of the market.

Learn More About Geographic Atrophy Market Report: https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the Major Highlights of the Geographic Atrophy Market Report:
• Geographic Atrophy market size increase forecasted over the study period 2019-2032 at a CAGR of approximately 30%.
• Worldwide, more than 5 million people are affected by geographic atrophy.
• In 2020, the total number of prevalent cases of geographic atrophy was 2,969,911 cases in 7MM. These cases are expected to increase with a significant CAGR over the 2019-2032 study period.
• In 7MM, the total number of treated cases of geographic atrophy was 1,267,314 cases in 2020.
• There is currently no approved treatment for geographic atrophy. Several major players such as Apellis Pharmaceuticals, NGM Biopharmaceuticals, Roche and many others are developing therapies for the treatment of geographic atrophy.
• NGM Biopharmaceuticals is currently conducting the Phase 2 CATALINA study, a multicenter, randomized, double-blind, simulation-controlled clinical trial to evaluate the safety and efficacy of intravitreal injections (IVT) of NGM621 in patients with geographic atrophy secondary to age. associated macular degeneration (AMD).
• NGM conducted a multicenter evaluation of NGM621 in an open-label, single-dose and multiple-dose study in participants with geographic atrophy secondary to age-related macular degeneration (NCT04014777).

Obtain more comprehensive insights on the impact of Geographic Atrophy epidemiological trends on the current and forecast Geographic Atrophy Market @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the geographic atrophy societies:
• Iveric Bio (formerly Ophthotech Corporation)
• Apellis Pharmaceuticals
• Hemera Biosciences
• Allegro Ophthalmic
• Stealth BioTherapeutics
• Alkeus Pharmaceuticals
• Therapeutic Gyroscope
• Regenerative patch technologies
• Roche/Genentech
• Ionis Pharmaceuticals/Roche
• CellCure Neurosciences (subsidiary of Lineage Cell Therapeutics)
• Janssen Research and Development
• And many more

Do you want to know what market share emerging therapies will capture by 2032? Contact @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

The launch of emerging therapies are expected to have a significant impact on the geographic atrophy treatment scenario in the coming years:-

Some of the geographic atrophy medications covered:
• Zimura (avacincaptad pegol)
• Pegcetacoplan
• HMR59/AAVCAGsCD59
• Risuteganib/ALG-1001/Luminate
• Elamipretide
• ALK-001
• GT005
• CPCB-RPE1
• RO7171009/RG6147
• IONIS-FB-LRx
• OpRegen
• Palucorcel/CNTO 2476
• And many more

Learn more about collaborations, tie-ups and the launch of therapies @ https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contents:
1. Key information
2. Executive Summary of Geographic Atrophy
3. Competitive Intelligence Analysis for Geography Atrophy
4. Geographic Atrophy: Market Overview at a Glance
5. Geographic Atrophy: Background and Overview of the Disease
6. Patient journey
7. Geographic atrophy epidemiology and patient population
8. Treatment Algorithm, Current Treatment and Medical Practices
9. Unmet Needs
10. Key Parameters of Geographic Atrophy Treatment
11. Marketed products
12. Emerging Therapies
13. Geographic atrophy: seven main market analyzes
14. Attribute Analysis
15. 7MM: Market Outlook
16. Geographic Atrophy Access and Reimbursement Overview
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Abilities

Free sample report request: https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Latest reports:

3D Cardiac Mapping System Market
https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Acanthamoeba Keratitis Market
https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Adult Growth Hormone Deficiency Market
https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Advanced Cancer Pain Management Market
https://www.delveinsight.com/report-store/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Apheresis market
https://www.delveinsight.com/report-store/apheresis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Arteriovenous Fistula Market
https://www.delveinsight.com/report-store/arteriovenous-fistula-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Automated External Defibrillator (AED) Market
https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Balloon Catheters Market
https://www.delveinsight.com/report-store/balloon-catheters-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Calciphylaxis Market
https://www.delveinsight.com/report-store/calciphylaxis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Brain Aneurysm Market
https://www.delveinsight.com/report-store/cerebral-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Idiopathic Urticaria Market
https://www.delveinsight.com/report-store/chronic-idiopathic-urticaria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact person: Ankit Nigam
Email: [email protected]
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About DelveInsight
DelveInsight is a leading business consultant and market research company focused exclusively on life sciences. It supports pharmaceutical companies by providing complete end-to-end solutions to improve their performance.

This press release was published on openPR.

Source link

About Chris Y. Camp

Check Also

US sues Idaho over abortion law, cites medical treatment

BOISE, Idaho (AP) — The Justice Department on Tuesday filed a lawsuit challenging Idaho’s restrictive …